Merck & Co., Inc. (MRK) Tops Q2 EPS by 2c

July 30, 2013 7:01 AM EDT
Merck & Co., Inc. (NYSE: MRK) reported Q2 EPS of $0.84, $0.02 better than the analyst estimate of $0.82. Revenue for the quarter came in at $11.01 billion versus the consensus estimate of $11.22 billion.

Merck & Co., Inc. reaffirmed FY2013 guidance.

For earnings history and earnings-related data on Merck & Co., Inc. (MRK) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities